SPECTRUM PHARMA LTD

Follow this company
Executive Summary

Spectrum Pharma Ltd exhibits a fragile financial position with severely diminished net assets and minimal working capital, indicating poor capability to service debt. The company’s micro-entity scale and sole director control further restrict resilience and risk mitigation. Credit facilities are not recommended at this stage without evidence of financial improvement or additional security.

View Full Analysis Report →
Company Documents

DateDescription
14/02/2514 February 2025 Confirmation statement made on 2024-12-06 with no updates

View Document

06/01/256 January 2025 Amended micro company accounts made up to 2022-12-31

View Document

31/12/2431 December 2024 Micro company accounts made up to 2023-12-31

View Document

09/01/249 January 2024 Confirmation statement made on 2023-12-06 with no updates

View Document

31/12/2331 December 2023 Annual accounts for year ending 31 Dec 2023

View Accounts

31/10/2331 October 2023 Micro company accounts made up to 2022-12-31

View Document

29/12/2229 December 2022 Confirmation statement made on 2022-12-06 with no updates

View Document

07/12/217 December 2021 Incorporation

View Document

More Company Information
Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
    • Follow this company